Development and evaluation of chitosan-coated liposomes for oral DNA vaccine: The improvement of Peyer's patch targeting using a polyplex-loaded liposomes

AAPS PharmSciTech

Volumn 12, Issue 1, 2011, Pages 192-200

  Channarong, Sunee ^a   Chaicumpa, Wanpen ^b   Sinchaipanid, Nuttanan ^a   Mitrevej, Ampol ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

chitosan; DNA vaccine; liposome; oral immunization; polyplex loaded liposome

Indexed keywords

CHITOSAN; CHOLESTEROL; DEOXYCHOLATE SODIUM; DNA VACCINE; GREEN FLUORESCENT PROTEIN; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG COATING; DRUG STABILITY; DRUG TARGETING; EVAPORATION; IN VIVO STUDY; INCUBATION TIME; LIPOSOMAL GENE DELIVERY SYSTEM; MALE; MOUSE; NONHUMAN; PEYER PATCH; PH; PRIORITY JOURNAL; ZETA POTENTIAL;

ADMINISTRATION, ORAL; ANIMALS; CHITOSAN; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EXCIPIENTS; HUMANS; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; PARTICLE SIZE; PEYER'S PATCHES; PHOSPHATIDYLCHOLINES; PLASMIDS; SURFACE PROPERTIES; VACCINES, DNA;

EID: 79954416540     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9559-9     Document Type: Article

References (35)

1. DL Montgomery JE Ulmer JJ Donnelly MA Liu 1997 DNA vaccines Pharmacol Ther 74 195 205 9336022 10.1016/S0163-7258(97)82003-7 1:CAS:528: DyaK2sXkvFChsLs%3D (Pubitemid 27337348)
2. MT Dertzbaugh 1998 Genetically engineered vaccines: an overview Plasmid 39 100 113 9514708 10.1006/plas.1997.1329 1:CAS:528:DyaK1cXhvFeiuro%3D (Pubitemid 28145071)
3. J Nugent AL Po EM Scott 1998 Design and delivery of non-parenteral vaccines J Clin Pharm Ther 23 257 285 9867311 1:CAS:528:DyaK1MXhsVyjsw%3D%3D (Pubitemid 28532450)
4. JR Kirman RA Seder 2003 DNA vaccination: the answer to stable, protective T-cell memory? Curr Opin Immunol 15 471 476 12900281 10.1016/S0952-7915(03) 00068-2 1:CAS:528:DC%2BD3sXlvFymurc%3D (Pubitemid 36930085)
5. I Takahashi T Nochi Y Yuki H Kiyono 2009 New horizon of mucosal immunity and vaccines Curr Opin Immunol 21 352 358 19493665 10.1016/j.coi.2009.04.002 1:CAS:528:DC%2BD1MXnsFOltrk%3D
6. P Yeh H Ellens PL Smith 1998 Physiological considerations in the design of particulate dosage forms for oral vaccine delivery Adv Drug Del Rev 34 123 133 10.1016/S0169-409X(98)00036-2 1:CAS:528:DyaK1cXnsFWltrk%3D (Pubitemid 28535108)
7. S Jain P Singh V Mishra SP Vyas 2005 Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B Immunol Lett 101 41 49 15869802 10.1016/j.imlet.2005.04.002 1:CAS:528: DC%2BD2MXhtVWhtLvI (Pubitemid 41297497)
8. M Conacher J Alexander JM Brewer 2001 Oral immunization with peptide and protein antigens by formulation in lipid particles incorporating bile salts (bilosomes) Vaccine 19 2965 2974 11282208 10.1016/S0264-410X(00)00537-5 1:CAS:528:DC%2BD3MXit1Wgtb0%3D (Pubitemid 32244290)
9. Ü Guliyeva F Öner S Özsoy R Haziroglu 2006 Chitosan microparticles containing plasmid DNA as potential oral gene delivery system Eur J Pharm Biopharm 62 17 25 16257520 10.1016/j.ejpb.2005.08.006 1:CAS:528:DC%2BD2MXht1Ontb7K (Pubitemid 41736020)
10. JFS Mann HE Scales E Sharkir J Alexander KC Carter AB Mullen, et al. 2006 Oral delivery of tetanus toxoid using particles significant systemic and mucosal immunity Methods 38 90 95 16414269 10.1016/j.ymeth.2005.11.002 1:CAS:528:DC%2BD28XhtVGisLg%3D (Pubitemid 43163468)
11. JFS Mann E Shakir KC Carter AB Mullen J Alexander VA Ferro 2009 Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection Vaccine 27 3643 3649 19464545 10.1016/j.vaccine.2009.03.040 1:CAS:528:DC%2BD1MXmtlKku7g%3D
12. K Khatri AK Goyal PN Gupta N Mishra A Mehta SP Vyas 2008 Surface modified liposomes for nasal delivery of DNA vaccine Vaccine 26 2225 2233 18396362 10.1016/j.vaccine.2008.02.058 1:CAS:528:DC%2BD1cXls1yqsLk%3D
13. DT Page S Cudmore 2001 Innovations in oral gene delivery: challenge and potentials DDT 6 2 92 101 11166257 1:CAS:528:DC%2BD3MXptVyrug%3D%3D (Pubitemid 32101511)
14. MC Filion NC Phillips 1998 Major limitations in the use of cationic liposomes for DNA delivery Int J Pharm 162 159 170 10.1016/S0378-5173(97)00423-7 1:CAS:528:DyaK1cXitVeqtLs%3D (Pubitemid 28166101)
15. S Dokka D Toledo X Shi V Castranova Y Rojanasakul 2000 Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes Pharm Res 17 521 525 10888302 10.1023/A:1007504613351 1:CAS:528:DC%2BD3cXksVGqtbc%3D (Pubitemid 30416388)
16. M Bivas-Benita M Laloup S Versteyhe J Dewit J de Braekeleer E Jongert, et al. 2003 Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies Int J Pharm 266 17 27 14559390 10.1016/S0378-5173(03)00377-6 1:CAS:528:DC%2BD3sXotVSjur4%3D (Pubitemid 37249304)
17. KA Howard XW Li S Somavarapu, et al. 2004 Formulation of a microparticle carrier for oral polyplex-based DNA vaccines Biochim Biophy Acta 1674 149 157 1:CAS:528:DC%2BD2cXnslGhsbg%3D (Pubitemid 40125386)
18. MR Almofti H Harashima Y Shinohara A Almofti Y Baba H Kiwada 2003 Cationic liposome-mediated gene delivery: biophysical study and mechanism of internalization Arch Biochem Biophys 410 2 246 253 12573284 10.1016/S0003- 9861(02)00725-7 (Pubitemid 36259824)
19. R Jayakumar KP Chennazhi RAA Muzzarelli H Tamura SV Nair N Selvamurugan 2010 Chitosan conjugated DNA nanoparticles in gene therapy Carbohydr Polym 79 1 8 10.1016/j.carbpol.2009.08.026 1:CAS:528:DC%2BD1MXht1yntbzJ
20. H Yamamoto Y Kuno S Sugimoto H Takeuchi Y Kawashima 2005 Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions J Control Release 102 373 381 15653158 10.1016/j.jconrel.2004.10.010 1:CAS:528: DC%2BD2MXktVCrug%3D%3D (Pubitemid 40093760)
21. C Prego M Garcí D Torres MJ Alonso 2005 Transmucosal macromolecular drug delivery J Control Release 101 151 162 15588901 10.1016/j.jconrel.2004.07.030 1:CAS:528:DC%2BD2cXhtVKgu7bJ (Pubitemid 39600979)
22. SM Van der Merwe JC Verhoef JHM Verheijden AF Kotzé HE Junginger 2004 Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs Eur J Pharm Biopharm 58 225 235 15296951 10.1016/j.ejpb.2004.03.023 (Pubitemid 39037231)
23. H Takeuchi Y Matsui H Sugihara H Yamamoto Y Kawashima 2005 Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs Int J Pharm 303 160 170 16125348 10.1016/j.ijpharm.2005.06.028 1:CAS:528:DC%2BD2MXhtVamsr7N (Pubitemid 41318033)
24. HO Alpar S Somavarapua KN Atuahb VW Bramwell 2005 Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery Adv Drug Del Rev 57 411 443 10.1016/j.addr.2004.09.004 1:CAS:528:DC%2BD2cXhtVSntbrP (Pubitemid 39550968)
25. HL Davis ML Michel RG Whalen 1993 DNA-based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody Hum Mol Genetics 2 1847 1851 10.1093/hmg/2.11.1847 1:CAS:528: DyaK2cXivV2nug%3D%3D (Pubitemid 23326610)
26. HQ Mao K Roy VL Troung-Le, et al. 2001 Chitosan-DNA nanoparticles as gene carrier: synthesis, characterization and transfection efficiency J Control Release 70 399 421 11182210 10.1016/S0168-3659(00)00361-8 1:CAS:528: DC%2BD3MXhtV2murs%3D (Pubitemid 32155463)
27. M Cócera O López L Coderch JL Parra A de la Maza 2003 Permeability investigations of phospholipid liposomes by adding cholesterol Colloid Surf A 221 9 17 10.1016/S0927-7757(03)00104-3 (Pubitemid 36802191)
28. SM Moghimi HM Patel 1988 Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes FEBS Lett 233 1 143 147 3384086 10.1016/0014-5793(88)81372-3 1:CAS:528:DyaL1cXktlKntLs%3D
29. J Guo Q Ping G Jiang L Huang Y Tong 2003 Chitosan-coated liposomes: characterization and interaction with leuprolide Int J Pharm 260 167 173 12842337 10.1016/S0378-5173(03)00254-0 1:CAS:528:DC%2BD3sXkvFekt7s%3D (Pubitemid 36773915)
30. RJ Mumper J Wang JM Claspell AP Rolland 1996 Novel polymeric condensing carriers for gene delivery Proc Int Symp Control Rel Bioact Mater 22 178 179
31. T Kiang J Wen HW Lim KW Leong 2004 The effect of the degree of chitosan deacetylation on the efficacy of gene transfection Biomaterials 25 5293 5301 15110480 10.1016/j.biomaterials.2003.12.036 1:CAS:528:DC%2BD2cXjtlylsL8%3D (Pubitemid 38523332)
32. W Liu S Sun Z Cao X Zhang K Yao WW Lu, et al. 2005 An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes Biomaterials 26 15 2705 2711 15585274 10.1016/j.biomaterials.2004.07.038 1:CAS:528:DC%2BD2cXhtVChsrvN (Pubitemid 39600723)
33. K Takeuchi K Ishihara C Kawaura M Noji T Furuno M Nakanishi 1996 Effect of zeta potential of cationic liposomes containing cationic cholesterol derivatives on gene transfection FEBS Lett 397 207 209 8955348 10.1016/S0014-5793(96)01136-2 1:CAS:528:DyaK28XmvFaqtrY%3D (Pubitemid 26414018)
34. K Bowman R Sarkar S Raut KW Leong 2008 Gene transfer to hemophilia A mice via oral delivery of FVIII-chitosan nanoparticles J Control Release 132 252 259 18634839 10.1016/j.jconrel.2008.06.019 1:CAS:528:DC%2BD1cXhsVensLjP
35. R Hejazi M Amiji 2003 Chitosan-based gastrointestinal delivery systems J Control Release 89 151 165 12711440 10.1016/S0168-3659(03)00126-3 1:CAS:528:DC%2BD3sXjtVegtbg%3D (Pubitemid 36507012)